Citadel Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $91.5K | Buy |
32,800
+5,300
| +19% | +$16.1K | ﹤0.01% | 12094 |
|
|
2025
Q4 | $114K | Sell |
27,500
-44,800
| -62% | -$236K | ﹤0.01% | 11528 |
|
|
2025
Q3 | $306K | Buy |
72,300
+3,200
| +5% | +$12K | ﹤0.01% | 10326 |
|
|
2025
Q2 | $146K | Sell |
69,100
-49,500
| -42% | -$74.1K | ﹤0.01% | 10984 |
|
|
2025
Q1 | $145K | Sell |
118,600
-460,100
| -80% | -$645K | ﹤0.01% | 10932 |
|
|
2024
Q4 | $747K | Buy |
578,700
+516,200
| +826% | +$1.24M | ﹤0.01% | 7657 |
|
|
2024
Q3 | $172K | Buy |
62,500
+48,900
| +360% | +$120K | ﹤0.01% | 10375 |
|
|
2024
Q2 | $30.7K | Buy |
13,600
+5,900
| +77% | +$17.9K | ﹤0.01% | 12243 |
|
|
2024
Q1 | $18.4K | Buy |
7,700
+4,400
| +133% | +$8.32K | ﹤0.01% | 13062 |
|
|
2023
Q4 | $5.48K | Buy |
+3,300
| New | +$6.4K | ﹤0.01% | 13425 |
|
|
2023
Q3 | – | Sell |
-9,700
| Closed | -$14K | – | 14596 |
|
|
2023
Q2 | $14K | Sell |
9,700
-7,900
| -45% | -$13.4K | ﹤0.01% | 13019 |
|
|
2023
Q1 | $37K | Buy |
17,600
+17,300
| +5,767% | +$27.9K | ﹤0.01% | 12523 |
|
|
2022
Q4 | $339 | Buy |
+300
| New | +$400 | ﹤0.01% | 14688 |
|
|
2022
Q2 | – | Sell |
-22,800
| Closed | -$37K | – | 13377 |
|
|
2022
Q1 | $37K | Sell |
22,800
-55,100
| -71% | -$107K | ﹤0.01% | 12986 |
|
|
2021
Q4 | $161K | Sell |
77,900
-6,600
| -8% | -$18.8K | ﹤0.01% | 12175 |
|
|
2021
Q3 | $328K | Buy |
84,500
+27,800
| +49% | +$94.2K | ﹤0.01% | 10872 |
|
|
2021
Q2 | $181K | Buy |
56,700
+32,200
| +131% | +$115K | ﹤0.01% | 12275 |
|
|
2021
Q1 | $53K | Sell |
24,500
-27,400
| -53% | -$61.4K | ﹤0.01% | 12875 |
|
|
2020
Q4 | $116K | Buy |
51,900
+10,700
| +26% | +$28.1K | ﹤0.01% | 10127 |
|
|
2020
Q3 | $110K | Buy |
41,200
+6,300
| +18% | +$17.6K | ﹤0.01% | 9218 |
|
|
2020
Q2 | $107K | Sell |
34,900
-6,000
| -15% | -$15.1K | ﹤0.01% | 8952 |
|
|
2020
Q1 | $80K | Sell |
40,900
-7,400
| -15% | -$18K | ﹤0.01% | 8786 |
|
|
2019
Q4 | $138K | Sell |
48,300
-5,000
| -9% | -$17.4K | ﹤0.01% | 8406 |
|
|
2019
Q3 | $196K | Buy |
53,300
+20,100
| +61% | +$72.6K | ﹤0.01% | 8166 |
|
|
2019
Q2 | $138K | Sell |
33,200
-45,900
| -58% | -$199K | ﹤0.01% | 8395 |
|
|
2019
Q1 | $404K | Sell |
79,100
-15,000
| -16% | -$72K | ﹤0.01% | 7147 |
|
|
2018
Q4 | $323K | Buy |
94,100
+14,100
| +18% | +$67.4K | ﹤0.01% | 7125 |
|
|
2018
Q3 | $481K | Buy |
80,000
+47,500
| +146% | +$261K | ﹤0.01% | 6758 |
|
|
2018
Q2 | $207K | Buy |
32,500
+16,500
| +103% | +$80.4K | ﹤0.01% | 7828 |
|
|
2018
Q1 | $76K | Sell |
16,000
-15,200
| -49% | -$70.8K | ﹤0.01% | 7806 |
|
|
2017
Q4 | $104K | Buy |
31,200
+10,000
| +47% | +$25.3K | ﹤0.01% | 7416 |
|
|
2017
Q3 | $45K | Sell |
21,200
-32,500
| -61% | -$64.4K | ﹤0.01% | 7205 |
|
|
2017
Q2 | $132K | Sell |
53,700
-2,000
| -4% | -$5.33K | ﹤0.01% | 6806 |
|
|
2017
Q1 | $128K | Buy |
55,700
+17,100
| +44% | +$25.8K | ﹤0.01% | 6764 |
|
|
2016
Q4 | $38K | Buy |
38,600
+12,700
| +49% | +$11.3K | ﹤0.01% | 6927 |
|
|
2016
Q3 | $29K | Buy |
+25,900
| New | +$46K | ﹤0.01% | 6967 |
|
|
2015
Q3 | – | Sell |
-1,300
| Closed | -$4K | – | 9012 |
|
|
2015
Q2 | $4K | Buy |
+1,300
| New | +$3.92K | ﹤0.01% | 8562 |
|
|
2015
Q1 | – | Sell |
-1,000
| Closed | -$3K | – | 8632 |
|
|
2014
Q4 | $3K | Sell |
1,000
-11,900
| -92% | -$52.6K | ﹤0.01% | 8334 |
|
|
2014
Q3 | $65K | Sell |
12,900
-9,700
| -43% | -$75.5K | ﹤0.01% | 6728 |
|
|
2014
Q2 | $312K | Sell |
22,600
-15,500
| -41% | -$193K | ﹤0.01% | 5022 |
|
|
2014
Q1 | $583K | Buy |
+38,100
| New | +$543K | ﹤0.01% | 4125 |
|
Other funds holding GALT
VCM
WANY
